Background
==========

It is very common that acute ischemic stroke patients have mild symptoms or rapidly improving stroke symptoms, which makes the decisions of treatment in dilemma. Intravenous thrombolysis with recombinant tissue plasminogen activator (IV rtPA) is proven to be the most effective treatment for acute ischemic stroke \[[@B1],[@B2]\]. However, only 1%-5% patients are treated with IV rtPA. In addition to the narrow time window for treatment, not treat patients with mild or rapidly improving symptoms is one important reason \[[@B3]\]. In studies evaluating eligibility for thrombolysis, up to 43% of patients with mild or improving stroke symptoms do not receive thrombolytic therapy because of clinicians think the natural course of these patients is benign \[[@B4]\]. However, according to recent reports, 15%--31% of patients with mild or rapidly improving symptoms have dependent or dead during hospital admission without thrombolysis \[[@B3],[@B5]-[@B7]\]. Therefore, early identification of these patients with poor outcome will contribute to the choice of early intervention to prevent the occurrence of poor outcomes. Studies suggest that mild stroke patients with large vessel occlusion are at a high risk for early neurological deterioration or poor outcome \[[@B8]\]. Imaging with advanced MRI is one possibility to guide treatment decision in mild stroke \[[@B9]-[@B11]\]. Therapies directed at the underlying mechanism will be more effective. But there is still lack of clinical outcomes in patients with different etiologic subtype. This study aims to observe clinical characteristics and explore the effect of different etiologic subtype on prognosis of mild stroke.

Methods
=======

Subjects
--------

Due to this is an observational study that will only assess outcomes in participants, all participants or their designated relatives provided verbal informed consent for obtaining relative prognostic information. This research project was approved by the Scientific Research Department of West China Hospital, which conformed to the local ethic criteria for human researches. We included acute ischemic stroke admitted consecutively to neurological wards of the West China Hospital, Sichuan University within 30 days of symptom onset between September. 01, 2009 to August. 31, 2011. All patients had a clinical diagnosis of stroke according to World Health Organization (WHO) criteria and intracranial hemorrhage were further excluded by CT or MRI scan in the hospital \[[@B12]\]. Patients with National Institute of Health Stroke Scale (NIHSS)≦3 were included \[[@B13]\] in this study.

Data collection
---------------

Details of patient demographies, vascular risk factors, Blood pressure (BP) on admission, laboratory test, brain image data and complications were recorded at the time of assessment using a standardized structured form. Vascular risk factors included hypertension (HTN), diabetes, dyslipidemia, coronary heart disease (CHD), history of stroke, status of smoking and alcohol. Severity of stroke was assessed using the NIHSS score. Medical complications include respiratory infection, urinary tract infection, electrolyte disturbances, hemorrhage of digestive tract and epilepsy. Determination of ischemic stroke etiology was according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria: large-artery atherosclerosis (LAA); small artery occlusion (SAO); cardioembolism (CE); stroke of other determined cause (OC); and stroke of undetermined cause (UND) \[[@B14]\].

Assessment of outcome
---------------------

The main outcomes were death and disability at 3 month after onset. Death was all-cause case fatality. Disability was defined as modified Rankin Scale (mRS) \> 2 \[[@B15]\]. Patients were followed-up by telephone call, clinic interview or letter inquiry. To ensure the quality of information collection, all investigators received training in the beginning according to our standard operational manual. All data were recorded in a structured data sheet. The outcome assessors were blinded to the information of patients. The poor outcome defined as death or disability (mRS \>2) at 3 months.

Statistical analysis
--------------------

Differences between two groups were tested using t test, Mann--Whitney U test or Chi-Square test where appropriate. Variables that were identified as significant in the univariate analyses (P \<0.10) were entered into multivariate logistic regression analyses. The multivariate logistical regression was used to analyze association between different etiologic subtype and clinical outcomes, adjusting for all potential confounders including age, sex, NIHSS on admission, vascular risk factors and complications et al. Data are reported with Relative Risk (RR) and 95% confidence intervals (CI). All statistical analyses were performed with SPSS for Windows, Version 16.0 (SPSS Inc.).

Results
=======

Baseline characteristics
------------------------

We included 1655 patients with acute ischemic stroke within 30 days of symptom onset. Of them, patients with mild stroke accounted for 41.1% (680/1655). The mean age was 62.54 [± 13.51]{.smallcaps} years (18--97 years). Males accounted for 65.4% (445/680). The median time of symptoms onset to admission was 72 hours (2--270 hours). The median of NIHSS on admission is 2(1--3). Of these patients, 21.5% large-artery atherosclerosis, 40.6% small-vessel disease, 7.5% cardioembolisms, 2.2% other causes and 28.2% undetermined causes. 3.8% (26/680) of cases admitted within 3 hours and 4.7% (32/680) admitted within 4.5 hours. However, no patient received rt-PA treatment. The common complications were 7.7% respiratory tract infection, 2.0% urinary tract infection, 2.2% electrolyte imbalances, 0.9% gastrointestinal bleeding and 0.4% secondary epilepsy. The proportion of case fatality and death/disability was 2.2% and 10.1% respectively at 3 months. In order to analyze the effect of specific etiology on prognosis of minor stroke, such as cardioembolisms, large-artery atherosclerosis, small-vessel disease, the patients with undetermined etiology were excluded from the following analysis. In addition, other causes were also excluded due to few patients were included in our study. So we keep a total of 453 cases for further analysis. Compared to patients without death or disability, patients with poor outcome were younger, had higher proportions of large-artery atherosclerosis or cardioembolisms and had high rate of complications of respiratory and urinary tract infection. Baseline characteristics of this cohort were described in Table [1](#T1){ref-type="table"}.

###### 

Characteristics of patients with minor stroke according to outcomes

  **Variates**                      **Death/disability N1 = 43**   **No death/disability N2 = 373**   **P value**
  --------------------------------- ------------------------------ ---------------------------------- -------------
  Age, years                        68.84 ± 10.03                  63.34 ± 12.61                      0.006
  Male, %                           25(58.1)                       257(68.9)                          0.153
  Time from onset, h                48                             48                                 0.418
  SBP on admission, mmHg            141.88 ± 25.96                 143.40 ± 21.38                     0.667
  DBP on admission, mmHg            83.28 ± 16.99                  84.13 ± 13.64                      0.708
  Hypertension, %                   26(60.5)                       222(59.5)                          0.905
  Diabetes mellitus, %              11(25.6)                       70(18.8)                           0.285
  Dyslipidemia, %                   3(7.0)                         31(8.3)                            1.000
  Coronary heart diseas, %          2(4.7)                         22(5.9)                            1.000
  History of ischemic stroke, %     1(2.3)                         22(5.9)                            0.493
  History of hemorrhagic stroke     2(4.7)                         3(0.8)                             0.086
  Alcohol, %                        6(14.0)                        80(20.3)                           0.251
  Smoking, %                        13(30.2)                       125(33.)                           0.665
  TOAST classification                                                                                0.055
  LAA                               16(37.2)                       110(29.5)                           
  SAO                               19(44.2)                       228(61.1)                           
  CE                                8(18.6)                        35(9.4)                             
  Respiratory infection, %          10(23.3)                       20(5.4)                            0.000
  Urinary tract infection, %        3(7.0)                         5(1.3)                             0.040
  Electrolyte disturbance, %        0(0.0)                         8(2.1)                             1.000
  Hemorrhage of digestive tract,%   1(2.3)                         3(0.8)                             0.355
  Epilepsy, %                       1(2.3)                         1(0.3)                             0.196

LAA: large-artery atherosclerosis.

SAO: small artery occlusion.

CE: cardioembolism.

The influence of etiologic subtype on outcomes at 3 month
---------------------------------------------------------

After adjustment of potential confounders, such as age, sex, NIHSS on admission and vascular risk factors et al., cardioembolism was the independent predictor of death or disability at 3rdmonth (RR = 3.395;95%CI 1.257 \~ 9.170) (Table [2](#T2){ref-type="table"}). Small vessel occlusion also was the independent predictor of good outcome at 3rd month (RR = 0.412;95%CI 0.202 \~ 0.842) (Table [3](#T3){ref-type="table"}). Large-artery atherosclerosis was not the independent predictor of death or disability, but had a trend of increasing death/disability (RR = 1.497; 95%CI 0.723 \~ 3.102) (data not shown). In addition, age, history of intracerebral hemorrhage and complications were independent predictive factor for death or disability at 3rd month across different etiologic subtype analysis.

###### 

Multivariate logistic analysis of the influence of cardioembolism on death/disability

  **Variates**                    **RR**   **95% CI**        **P value**
  ------------------------------- -------- ----------------- -------------
  Age                             1.037    1.003 \~ 1.073    .031
  Gender                          .628     .276 \~ 1.426     .266
  Time from onset                 1.002    1.000 \~ 1.004    .107
  SBP on admission                .992     .969 \~ 1.015     .486
  DBP on admission                1.008    .972 \~ 1.045     .668
  Hypertension                    1.313    .610 \~ 2.826     .486
  Diabetes mellitus               1.263    .533 \~ 2.989     .596
  Hypercholesterolemia            1.188    .317 \~ 4.448     .798
  Coronary heart diseas           .321     .060 \~ 1.708     .183
  History of ischemic stroke      .228     .025 \~ 2.070     .189
  History of hemorrhagic stroke   11.297   1.469 \~ 86.889   .020
  Alcohol                         .619     .208 \~ 1.848     .390
  Smoking                         1.620    .644 \~ 4.072     .305
  CE VS. Non-CE                   3.395    1.257 \~ 9.170    .016
  Complications                   3.405    1.527 \~ 7.596    .003

CE: cardioembolism.

###### 

Multivariate logistic analysis of the influence of SAO on death/disability

  **Variates**                    **RR**   **95% CI**         **P value**
  ------------------------------- -------- ------------------ -------------
  Age                             1.035    1.002 \~ 1.069     .039
  Gender                          .614     .270 \~ 1.398      .245
  Time from onset                 1.001    .999 \~ 1.003      .306
  SBP on admission                .987     .965 \~ 1.010      .256
  DBP on admission                1.014    .978 \~ 1.051      .449
  Hypertension                    1.428    .659 \~ 3.095      .367
  Diabetes mellitus               1.276    .536 \~ 3.041      .582
  Hypercholesterolemia            1.114    .301 \~ 4.124      .871
  Coronary heart diseas           .437     .088 \~ 2.170      .311
  History of ischemic stroke      .265     .029 \~ 2.425      .240
  History of hemorrhagic stroke   12.420   1.423 \~ 108.367   .023
  Alcohol                         .628     .209 \~ 1.886      .407
  Smoking                         1.600    .630 \~ 4.063      .323
  SAO VS. Non-SAO                 .412     .202 \~ .842       .015
  Complications                   3.477    1.536 \~ 7.869     .003

SAO: small artery occlusion.

Discussion
==========

In this study, we found patients with mild stroke accounted for 41.1% in our cohort. The proportion of case fatality and death/disability was 2.2% and 10.1% respectively at 3 month. Different etiologic subtype can predict the outcome in these patients.

Previous studies showed the proportion of mild stroke veried from 5.8% to 62.3% based on different criteria, which in accordance with our study \[[@B16],[@B17]\]. Khatri et al. suggests that approximately one third of so-called mild strokes have significant disability (mRS 2--6) that persists at 3 months \[[@B7]\]. In contrast, we found 10.1% of minor stroke had death or disability. The reasons of low proportion of our study may be as follows: (1) they used the NIHSS≦5 as criteria whereas we used NIHSS≦3, which indicates they included participants more severer than ours; (2) they measured disability with mRS \> 1 whereas we defined it as mRS \> 2; (3) they enrolled patients within 24 hours whereas we included them within 30 days, which means their participants may be prone to have early worsening or early recurrence than ours; (4) In general, the death or disability of acute ischemic stroke patients in China is lower than abroad \[[@B18],[@B19]\], so may be minor stroke no exception.

Several studies reported the predictors of poor outcome of mild stroke, such as age, diabetes, coronary heart disease, smoking, and vessel stenosis or occlusion were predictor of death or disability or recurrence at the end of follow up period \[[@B20]-[@B25]\]. Ferrari J et al. found hypertension, diabetes, cardiac decompensation, acute infection, and stroke etiology (LAA and CE) emerged as independent risk predictors for early deterioration in patients with a transient ischaemic attack (TIA) or minor ischemic stroke, defined by an NIHSS score \<4 \[[@B26]\]. In our cohort, age, history of intracerebral hemorrhage, infections and etiologic subtype (CE and SAO) were the independent predictors of death or disability at 3rd month. Our finding of etiologic subtype can predict outcome in mild stroke is more compelling, because consecutive subjects that were assessed beyond hospital discharge at 90 days. So far, although there are no identical variates for predicting the poor outcome of patients with minor stroke, future studies are needed to focus on how to really identify minor stroke patients with poor outcome by clinical features combined with imaging features. Recently, Strbian D et al. indicates that half of patients presenting with NIHSS 0--6 developed an infarction despite thrombolysis, and 40% had poor outcome. Perhaps, urgent multimodal imaging can help to identify mild stroke at risk of worsening \[[@B27]\]. As we known, etiologic subtype help stratify patients for secondary prevention and it may also be used for identifing poor outcome in patients with mild stroke.

At present, whether patients presenting with mild stroke should or should not be treated with intravenous rtPA is still unclear. In our study, 3.8% (26/680) of cases admitted within 3 hours and 4.7% (32/680) admitted within 4.5 hours. However, no patient received intravenous thrombolysis. In the light of the natural history of course of mild stroke is not always benign, before a large randomized trial proving its lack of benefit in mild stroke patients, IV t-PA should be considered in these patients.

Our study has several limitations. (1) It was performed in a single-center, which may not represent for whole Chinese population; (2) there is no consensus definition of mild stroke. The National Institute of Neurological Disorders and Stroke (NINDS) rtPA study and the European Cooperative Acute Stroke Study (ECASS) III both excluded patients with mild stroke, but they failed to clearly define a certain threshold for a mild stroke. We used diagnostic criteria NIHSS score ≦3, which be evaluated as the more suitable cutoff point \[[@B13]\]; (3) The effects of potential unknown confounders cannot be ruled out in our cohort. Despite these limitations, our study explored the relationship between etiologic subtype and outcomes by inclusion of propectively consecutive patients and the blind evaluation of the study outcome.

Conclusions
===========

In conclusion, our study indicates that different etiologic subtype can predict the outcome in patients with minor stroke it can help to stratify these patients for individual decision-making.
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